[HTML][HTML] Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions

A Dey, R Bhattacharya, A Mukherjee… - Biotechnology advances, 2017 - Elsevier
Alzheimer's disease (AD) is a severe, chronic and progressive neurodegenerative disease
associated with memory and cognition impairment ultimately leading to death. It is the …

[HTML][HTML] Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands—A review

BJ Jongkees, B Hommel, S Kühn, LS Colzato - Journal of psychiatric …, 2015 - Elsevier
Consuming the amino-acid tyrosine (TYR), the precursor of dopamine (DA) and
norepinephrine (NE), may counteract decrements in neurotransmitter function and cognitive …

Ten questions concerning occupant health in buildings during normal operations and extreme events including the COVID-19 pandemic

M Awada, B Becerik-Gerber, S Hoque, Z O'Neill… - Building and …, 2021 - Elsevier
Even before the COVID-19 pandemic, people spent on average around 90% of their time
indoors. Now more than ever, with work-from-home orders in place, it is crucial that we …

Iron and attention deficit/hyperactivity disorder: What is the empirical evidence so far? A systematic review of the literature

S Cortese, M Angriman, M Lecendreux… - Expert review of …, 2012 - Taylor & Francis
The authors systematically reviewed evidence on iron status, as well as studies of iron
supplementation, in individuals with attention deficit/hyperactivity disorder (ADHD). PubMed …

[HTML][HTML] Towards the new generation of courtyard buildings as a healthy living concept for post-pandemic era

P Saadatjoo, P Badamchizadeh… - Sustainable Cities and …, 2023 - Elsevier
COVID-19 has laid a context for holistic research and practical approaches towards health
issues in buildings. This study focuses on one particular residential building type, which is a …

The effect of phosphatidylserine administration on memory and symptoms of attention‐deficit hyperactivity disorder: A randomised, double‐blind, placebo‐controlled …

S Hirayama, K Terasawa, R Rabeler… - Journal of human …, 2014 - Wiley Online Library
Background Attention‐deficit hyperactivity disorder (ADHD) is the most commonly
diagnosed behavioural disorder of childhood, affecting 3–5% of school‐age children. The …

The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and …

F Catalá-López, B Hutton, A Núñez-Beltrán… - Systematic reviews, 2015 - Springer
Background Attention deficit hyperactivity disorder (ADHD) is one of the most common
neurodevelopmental disorders of children and adolescents, with a significant impact on …

Viloxazine in the treatment of attention deficit hyperactivity disorder

AN Edinoff, HA Akuly, JH Wagner… - Frontiers in …, 2021 - frontiersin.org
Attention deficit hyperactivity disorder (ADHD) is the most common neurodevelopmental
disorder in children. Over the past twenty years, research on the disease and its …

An increase in dietary supplement exposures reported to US poison control centers

N Rao, HA Spiller, NL Hodges, T Chounthirath… - Journal of medical …, 2017 - Springer
Introduction The objective of this study was to investigate the epidemiology of dietary
supplement exposures in the USA. Methods A retrospective analysis was conducted of out …

Fruit and vegetable intake is inversely associated with severity of inattention in a pediatric population with ADHD symptoms: The MADDY Study

LM Robinette, IE Hatsu, JM Johnstone… - Nutritional …, 2023 - Taylor & Francis
ABSTRACT Objectives Attention Deficit Hyperactivity Disorder (ADHD) is a
neurodevelopmental disorder with a US pediatric prevalence of 8–10%. It presents with …